A study published in July 2021 in the Journal of Clinical Oncology has shown that the overall survival (OS) in patients who had previously treated esophageal cancer improved significantly with the humanized monoclonal antibody drug tislelizumab when compared to chemotherapy (J Clin Oncol. 2021 39:15_suppl, 4012-4012; the study was sponsored by BeiGene, Ltd.). In the global […]
Articles tagged with "head and neck cancer"
A look at the effect of endovascular intervention or extracranial/intracranial (EC/IC) vascular bypass on the management of patients with head and neck cancer-related rupture of the extracranial carotid artery or its major branches.
Most cases of oropharyngeal cancer are positive for the human papillomavirus, but among Blacks, 55.3% of cases are HPV-negative, and HPV-negative cases are, to say the least, understudied, said Babak Givi, MD, associate professor of otolaryngology–head and neck surgery at New York University Grossman School of Medicine, in a virtual session at the Combined Otolaryngology […]
A new study published in the Journal of Experimental Medicine has shown that up to half of patients with head and neck squamous cell carcinoma will experience tumor recurrence or new tumors, which often spread and are difficult to treat (J Exp Med. 2021;218:e20200944). The team of researchers, led by the University of Michigan School […]
Pretreatment sarcopenia as radiologically defined by decreased skeletal muscle index (SMI) or skeletal muscle mass (SMM) correlates with poor survival in HNC patients.
A look at the impact of regression on sentinel node status and the likelihood of recurrence in primary cutaneous melanoma of the head and neck.
Circulating tumor cells are not associated with prognosis in patients with locally advanced and metastatic squamous cell carcinoma of the head and neck (SCCHN), but circulating tumor cells (CTCs) are present.
Transoral laser microsurgery is associated with better outcomes than radiotherapy in overall survival, confidence interval, disease-specific survival, and laryngeal preservation in patients with T1 glottic carcinoma.
A look at how pathologic features contribute to clinical outcomes of early oral tongue squamous cell carcinoma relative to tumor depth of invasion.